02/2023. Review about MV140 (Uromune)

The journal Pathogens publishes a comprehensive review of the MV140 (Uromune) vaccine produced by INMUNOTEK.   

MV140 is a sublingual mucosal bacterial vaccine designed to combat recurrent urinary tract infections (recurrent cystitis).  These infections mostly affect women and are usually treated with antibiotics.

The review by J. Curtis Nickel and R. Christopher Doiron (Department of Urology, Queen’s University, Kingston, Ontario, Canada) provides a comprehensive review of the clinical evidence of immunoprophylaxis with MV140, mechanism of action and pharmacoeconomic data published in the scientific literature.